| Literature DB >> 33563672 |
Zia Saleh1, Susan Koshy2, Vaninder Sidhu2, Andrea Opgenorth3, Janek Senaratne4.
Abstract
Spontaneous coronary artery dissection (SCAD) is a rare but increasingly recognised cause of acute coronary syndrome. While numerous risk factors are associated with SCAD, one potential cause is coronary artery vasospasm. The use of cabergoline-an ergot derivative and dopamine agonist that may induce vasospasm-has been associated with SCAD in one other case report worldwide. Here, we describe SCAD in a 37-year-old woman on long-term cabergoline therapy with no other cardiac risk factors. Cabergoline-induced SCAD should be considered in patients presenting with an acute coronary syndrome who are treated with this medication. © BMJ Publishing Group Limited 2021. No commercial re-use. See rights and permissions. Published by BMJ.Entities:
Keywords: cardiovascular medicine; drugs: endocrine system
Year: 2021 PMID: 33563672 DOI: 10.1136/bcr-2020-240022
Source DB: PubMed Journal: BMJ Case Rep ISSN: 1757-790X